ライフサイエンスコーパス: pluripotent stem cell

1 o generate pancreatic progenitors from human pluripotent stem cells.

2 human cardiac myocytes derived from induced pluripotent stem cells.

3 domain, into marmoset embryonic and induced pluripotent stem cells.

4 inhibitory neurons differentiated from human pluripotent stem cells.

5 nd cardiomyocytes derived from human induced pluripotent stem cells.

6 tructural features of the liver, using human pluripotent stem cells.

7 increased CAG repeat expansion in HD-induced pluripotent stem cells.

8 on the majority of RNA:DNA hybrids in human pluripotent stem cells.

9 d imprinting errors in embryonic and induced pluripotent stem cells.

10 ystem that generates complex skin from human pluripotent stem cells.

11 tem cells and, more recently, derivatives of pluripotent stem cells.

12 in cardiomyocytes, DNMT3A, in human induced pluripotent stem cells.

13 in touch neurons derived from human induced pluripotent stem cells.

14 i of cells within micropatterned colonies of pluripotent stem cells.

15 th early cardiac and neural development from pluripotent stem cells.

16 human cardiac myocytes derived from induced pluripotent stem cells.

17 rating similar lung epithelial lineages from pluripotent stem cells.

18 te differentiation of isogenic human induced pluripotent stem cells.

19 e feature of mammalian development and naive pluripotent stem cells.

20 binding for chromatin localization in human pluripotent stem cells and in turn for defining cellular

21 In both induced pluripotent stem cells and induced neurons, gene copy nu

22 dification that specifies the basic state of pluripotent stem cells and regulates the developmental t

23 e the conversion of somatic cells to induced pluripotent stem cells and rejuvenation of the germline

24 an islet-like organoids (HILOs) from induced pluripotent stem cells and show that non-canonical WNT4

25 how single-cell technologies, human-induced pluripotent stem cells and systems pharmacogenomics acce

26 single DNA molecules in the genome of mouse pluripotent stem cells and using CRISPR/Cas9-mediated en

27 n pneumocyte-like cells derived from induced pluripotent stem cells, and apilimod also demonstrated a

28 like cells differentiated from human induced pluripotent stem cells are further induced into M-prospe

29 e brain organoids and assembloids from human pluripotent stem cells are increasingly utilized to mode

30 Overall the results suggest that pluripotent stem cells are not subject to unusually high

31 emergence of brain organoids generated from pluripotent stem cells as a model to compensate for the

32 Using isogenic human pluripotent stem cells as a model to investigate the pat

33 cortical neurons differentiated from induced pluripotent stem cells, as well as post-mortem tissue fr

34 e of high-throughput assays in human induced pluripotent stem cell-based neurodevelopmental models to

35 Here we developed an induced pluripotent stem cell-based three-dimensional model that

36 DNMT3A was knocked out in human induced pluripotent stem cells by CRISPR/Cas9gene editing.

37 on of developmental transcription factors in pluripotent stem cells by methylating lysine 27 on histo

38 re, we tackle this question in human induced pluripotent stem cells by using multiple complementary a

39 caftor treatment in patient-specific induced pluripotent stem cell-cardiomyocytes (iPSC-CMs) derived

40 plore mesoderm lineage-bias within the human pluripotent stem cell compartment.

41 ement based on generating neurons from human pluripotent stem cells could effectively treat in the fu

42 The immature phenotype of human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs)

43 re we evaluate if transplantation of induced pluripotent stem cell derived TM like cells (iPSC-TM) re

44 Mutant TNNT2:p.R286H iPSC-CMs (induced pluripotent stem cells derived cardiomyocytes) show hype

45 In this study, both induced pluripotent stem cells derived from a MFS-patient and th

46 ic lineage cells differentiated from induced pluripotent stem cells derived from an affected individu

47 ntitative phosphoproteomic survey of induced pluripotent stem cell-derived AT2s (iAT2s) infected with

48 epithelium with SARS-CoV-2 by using induced pluripotent stem cell-derived AT2s that have been adapte

49 ding EndoC-beta cell lines and human induced pluripotent stem cell-derived beta-like cells.

50 reduced FcRn engagement across human induced pluripotent stem cell-derived brain endothelial-like cel

51 characterization conducted in human induced pluripotent stem cell-derived cardiac myocytes (hiPSC-CM

52 type-Tissue Expression) and in human-induced pluripotent stem cell-derived cardiac myocytes deficient

53 impacted by recent advances in human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) t

54 his process and lead to better maturation of pluripotent stem cell-derived cardiomyocyte and novel th

55 on recently due to the maturation defects in pluripotent stem cell-derived cardiomyocyte, its antagon

56 these signaling modulators to human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

57 c kidney (HEK293) cells and in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

58 Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

59 ventricular cardiomyocytes and human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

60 s for creating cardioprotective drugs, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs)

61 signals on human cardiomyocytes, using human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs)

62 The development of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs)

63 We previously reported that induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs)

64 A primary limitation in the use of pluripotent stem cell-derived cardiomyocytes (PSC-CMs) f

65 Pluripotent stem cell-derived cardiomyocytes (PSC-CMs) h

66 Accumulating evidence suggests that human pluripotent stem cell-derived cardiomyocytes can affect

67 Functional studies on human induced pluripotent stem cell-derived cardiomyocytes demonstrate

68 iac pathogenesis in patient-specific induced pluripotent stem cell-derived cardiomyocytes from NS pat

69 PHTF1 was upregulated in human-induced pluripotent stem cell-derived cardiomyocytes from patien

70 Using human induced pluripotent stem cell-derived cardiomyocytes in cardiac

71 Patients' induced pluripotent stem cell-derived cardiomyocytes recapitulat

72 In human induced pluripotent stem cell-derived cardiomyocytes, GS-967 and

73 s of LQTS type 2 (LQTS2) using human induced pluripotent stem cell-derived cardiomyocytes, KCNQ1 anti

74 urrent (I (NaP)) recorded from human induced pluripotent stem cell-derived cardiomyocytes.

75 HL1 murine cardiomyocytes and human induced pluripotent stem cell-derived cardiomyocytes.

76 red heart tissue from knockout human induced pluripotent stem cell-derived cardiomyocytes.

77 Induced pluripotent stem cell-derived dopaminergic cultures reve

78 patient-derived skin fibroblasts or induced pluripotent stem cell-derived dopaminergic neurons.

79 Our results demonstrate that human pluripotent stem cell-derived glomeruli can develop an a

80 s cultured primary human hepatocytes (PHHs), pluripotent stem cell-derived hepatocyte-like cells (HLC

81 , they received either endobronchial induced pluripotent stem cell-derived human MSCs (hMSCs) (n = 7)

82 arization and subsequent maturation of human pluripotent stem cell-derived kidney organoids after ren

83 lomerular function in the transplanted human pluripotent stem cell-derived kidney tissue 1, 2, and 3

84 systems from primary mouse and human induced pluripotent stem cell-derived lung epithelial cells to m

85 Using induced pluripotent stem cell-derived megakaryocyte clones that

86 we used genetically engineered human induced pluripotent stem cell-derived microglia-like cells to sh

87 ovo in schizophrenia, and studies of induced pluripotent stem cell-derived neural progenitor cells.

88 both the prefrontal cortex (PFC) and induced pluripotent stem cell-derived neuronal cultures from pat

89 Truncated STMN2 accumulated in human induced pluripotent stem cell-derived neurons depleted of TDP-43

90 erentiation into excitatory neurons, induced pluripotent stem cell-derived neurons from all three pat

91 On human induced pluripotent stem cell-derived neurons, the nanobody prev

92 KPNA7-interacting proteins in human induced pluripotent stem cell-derived neurons.

93 ophagy, promoting viability of human induced pluripotent stem cell-derived neurons.

94 ptake in H4 neuroglioma cells and in induced pluripotent stem cell-derived neurons.

95 ockout (CISH(-/-)) NK cells using an induced pluripotent stem cell-derived NK cell (iPSC-NK cell) pla

96 n, we optimized a protocol to generate human pluripotent stem cell-derived Purkinje cells (hPSC-PCs)

97 y was validated using clinical-grade induced pluripotent stem cell-derived retinal pigment epithelial

98 Here, we utilized induced pluripotent stem cell-derived retinal pigment epithelium

99 cessible Chromatin using sequencing on human pluripotent stem cell-derived SAN-like pacemaker cells a

100 We found that human induced pluripotent stem cell-derived sensory neurons expressed

101 the nucleus utilizing isogenic human-induced pluripotent stem cells-derived neurons from PD patients

102 ifferentiation protocol for generating human pluripotent stem-cell-derived beta (SC-beta) cells with

103 Here, we use primate pluripotent stem-cell-derived cardiomyocytes that mimic

104 Indeed, previous human pluripotent stem-cell-derived models of kidney tissue ei

105 ered in nuclei isolated from C9orf72 induced pluripotent stem-cell-derived neurons (iPSNs).

106 ing a model of chronic HIF1a accumulation in pluripotent-stem-cell-derived oligodendrocyte progenitor

107 Dmd C3333Y animals, induced-pluripotent-stem-cell-derived skeletal muscle cells from

108 Pluripotent stem cells differentiate with varying effici

109 type specification, with broad relevance for pluripotent stem cell differentiation and disease modeli

110 lex and coordinated pathway originating from pluripotent stem cells during embryogenesis and continui

111 hus, we identify chromosome-bound factors in pluripotent stem cells during mitosis and reveal that PR

112 human cardiac myocytes derived from induced pluripotent stem cells during oxidative stress.

113 ates the usefulness of using patient-induced pluripotent stem cells for targeted discovery and valida

114 Here we generated induced pluripotent stem cells from 15 individuals with 22q11DS

115 ultures containing dopamine neurons, induced pluripotent stem cells from patients with YOPD showed in

116 Conversion of human pluripotent stem cells from primed to naive state is acc

117 patient-specific model, we generated induced pluripotent stem cells from three patients with missense

118 Induced pluripotent stem cells, from 3 patients with the 15q13.3

119 tem cells (WA-01, passage 27-40) and induced pluripotent stem cells (GM23338) with a series of chemic

120 as their recapitulation in vitro from human pluripotent stem cells has the potential to generate aut

121 redible advances in cell biology, namely, in pluripotent stem cells, have also contributed to the lat

122 tem and progenitor cells, stromal cells, and pluripotent stem cells, have been investigated over the

123 ting therapeutic strategy in a human induced pluripotent stem cell (hiPSC)-based in vitro model of ne

124 Coupling human induced pluripotent stem cell (hiPSC)-based technology with CRIS

125 to purify fetal astrocytes and human induced pluripotent stem cell (hiPSC)-derived astrocytes.

126 thy using DMD patient-specific human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and

127 odeling cardiac disorders with human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes is

128 stigated the susceptibility of human induced pluripotent stem cell (hiPSC)-derived monolayer brain ce

129 ng cholesterol biosynthesis in human induced pluripotent stem cell (hiPSC)-derived neuroprogenitors u

130 our study, the RPE identity of human induced pluripotent stem cell (hiPSC)-derived RPE (iRPE) was ext

131 of EpCAM(+) cells derived from human induced pluripotent stem cells (hiPSC) at the physiological air-

132 nd disease-primed conventional human induced pluripotent stem cells (hiPSC) can be significantly impr

133 Human-induced pluripotent stem cells (hiPSCs) allow for the establishm

134 Human induced pluripotent stem cells (hiPSCs) are a powerful model of

135 ) retinal organoids (ROs) from human induced pluripotent stem cells (hiPSCs) derived from an LCA4 pat

136 Towards this, patient-derived human induced pluripotent stem cells (hiPSCs) have demonstrated consid

137 Human induced pluripotent stem cells (hiPSCs) have revolutionized rese

138 We differentiated human induced pluripotent stem cells (hiPSCs) into NPCs to generate tw

139 be a protocol to differentiate human induced pluripotent stem cells (hiPSCs) into oogonia in vitro.

140 itor cells (NPCs) derived from human induced pluripotent stem cells (hiPSCs) of ASD individuals with

141 blastocysts were injected with human induced pluripotent stem cells (hiPSCs) or hiPSCs overexpressing

142 Human induced pluripotent stem cells (hiPSCs) provide a potentially un

143 Human induced pluripotent stem cells (hiPSCs) provide a powerful platf

144 paradigm using genetically engineered human pluripotent stem cells (hiPSCs) that captures authentic

145 ation of SALL4 was examined in human induced pluripotent stem cells (hiPSCs) that were differentiated

146 re of brain tissue.We employed human induced pluripotent stem cells (hiPSCs) to compare patterns of A

147 IMPORTANCE This study employed human induced pluripotent stem cells (hiPSCs) to model the interaction

148 these phenotypes, 65 clones of human induced pluripotent stem cells (hiPSCs) were generated from 13 i

149 splice regulatory elements in human induced pluripotent stem cells (hiPSCs), and develop a software

150 nt gene expression profiles in human induced pluripotent stem cells (hiPSCs), indicating isoform-spec

151 0 and ~12 200 loci in 293T and human induced pluripotent stem cells (hiPSCs), respectively, three ord

152 rived from clinically relevant human induced pluripotent stem cells (hiPSCs).

153 In this study, we take advantage of a human pluripotent stem cell (hPSC) differentiation system and

154 cell cultures generated from multiple human pluripotent stem cell (hPSC) myogenic differentiation pr

155 Here, we present a multiplex human pluripotent stem cell (hPSC) platform, in which 30 isoge

156 Here, we develop a human pluripotent stem cell (hPSC)-based microglial chimeric m

157 We report a 96-well-based array of 3D human pluripotent stem cell (hPSC)-derived cardiac microtissue

158 pidly-expanding therapeutic potential, human pluripotent stem cell (hPSC)-derived cell therapies cont

159 uman endocardial cells, we generated a human pluripotent stem cell (hPSC)-derived endothelial populat

160 Human pluripotent stem cell (hPSC)-derived intestinal organoid

161 Human pluripotent stem cell (hPSC)-derived neurons are a promi

162 Archetypal human pluripotent stem cells (hPSC) are widely considered to b

163 Naive human pluripotent stem cells (hPSC) resemble the embryonic epi

164 developed a lung organoid model using human pluripotent stem cells (hPSC-LOs).

165 ranscriptomics between differentiating human pluripotent stem cells (hPSCs) and developing mouse neur

166 In this report, human pluripotent stem cells (hPSCs) are subject to directed d

167 We investigate how human pluripotent stem cells (hPSCs) differentiate into pancre

168 Human pluripotent stem cells (hPSCs) offer an unprecedented op

169 Naive human pluripotent stem cells (hPSCs) provide a unique experime

170 The in vitro differentiation of human pluripotent stem cells (hPSCs) recapitulates some of the

171 Parallel studies using human pluripotent stem cells (hPSCs) revealed that HOXA(neg/lo

172 stablished method to generate ECs from human pluripotent stem cells (hPSCs), and then we overexpresse

173 a CLDN5-P2A-GFP stable cell line from human pluripotent stem cells (hPSCs), directed their different

174 we generate different SM subtypes from human pluripotent stem cells (hPSCs), which previously have be

175 in cardiomyocyte differentiation from human pluripotent stem cells (hPSCs).

176 of cell and organoid derivatives from human pluripotent stem cells (hPSCs).

177 ene studies and genome-wide screens in human pluripotent stem cells (hPSCs).

178 and mechanical stimulation of human induced pluripotent stem cells in 6-well plates.

179 subtelomeres, and at higher levels in mouse pluripotent stem cells in comparison with mouse embryoni

180 It is well established that pluripotent stem cells in fetal and postnatal liver (LPC

181 Plants maintain populations of pluripotent stem cells in shoot apical meristems (SAMs),

182 man development, we examine the potential of pluripotent stem cells in the context of bioprinting tow

183 e of 'cross-antagonistic' signalling to trap pluripotent stem cell intermediates with different linea

184 ith improved protocols differentiating human pluripotent stem cells into beta-like cells has opened u

185 hese transcription factors swiftly converted pluripotent stem cells into oocyte-like cells that were

186 otocols have been published to differentiate pluripotent stem cells into RPE cells suitable for disea

187 astrocytes differentiated from human-induced pluripotent stem cells into the mouse cortex.

188 s critical to the transformation of nonpolar pluripotent stem cells into the polarized epiblast epith

189 RNA-seq based analysis of 310 induced pluripotent stem cell (iPSC) clones derived from 100 ind

190 s, are differentially spliced during induced pluripotent stem cell (iPSC) differentiation and in tumo

191 In response to this need, an induced pluripotent stem cell (iPSC) disease model has been used

192 ene networks dysregulated in a human induced pluripotent stem cell (iPSC) disease model of a common f

193 emonstrate complete correction of an induced pluripotent stem cell (iPSC) line derived from a C9orf72

194 Using five control induced pluripotent stem cell (iPSC) lines and seven iPSC lines

195 Cultures of isogenic induced pluripotent stem cell (iPSC) lines with and without PARK

196 enic, CRISPR-modified TREM2-knockout induced pluripotent stem cell (iPSC) lines.

197 Recently, human- induced pluripotent stem cell (iPSC) models revealed an importan

198 ar envelope invaginations in patient induced pluripotent stem cell (iPSC) neurons and postmortem tiss

199 e, we report the generation of human induced pluripotent stem cell (iPSC) reporter lines in which flu

200 seases and conditions in which human induced pluripotent stem cell (iPSC)-based regenerative medicine

201 n this study, we established a human induced pluripotent stem cell (iPSC)-derived air-liquid interfac

202 To this end, we deployed human-induced pluripotent stem cell (iPSC)-derived BMEC-like cells as

203 0 nM - 100 muM) for effects in human induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CMs

204 an cell lines and one specific line, induced pluripotent stem cell (iPSC)-derived cardiomyocytes, as

205 Mature induced pluripotent stem cell (iPSC)-derived cortical neurons se

206 Notably, in static human induced pluripotent stem cell (iPSC)-derived HE culture, compoun

207 Armed with patient-derived cell lines and pluripotent stem cell (iPSC)-derived kidney organoids, i

208 therefore used highly enriched human induced pluripotent stem cell (iPSC)-derived motor neurons and a

209 creased 5-HT concentrations in human induced pluripotent stem cell (iPSC)-derived neuron culture medi

210 ast lines and generated six lines of induced pluripotent stem cell (iPSC)-derived neurons covering a

211 Using human induced pluripotent stem cell (iPSC)-derived neurons that model

212 genome sequencing (WGS) with patient-induced pluripotent stem cell (iPSC)-derived retinal organoids (

213 sociated genetic mutation in patient induced pluripotent stem cell (iPSC)-derived SNOs.

214 ere, we report the generation of two induced pluripotent stem cell (iPSC)-lines from patients with ra

215 ehensive proteomic analysis of human induced pluripotent stem cells (iPSC), a key cell type for disea

216 In this study, induced pluripotent stem cells (iPSC)-derived neuronal stem cell

217 ells and cardiomyocytes derived from induced pluripotent stem cells (iPSCs) and used a monomeric Fc-l

218 to produce cardiomyocytes from human induced pluripotent stem cells (iPSCs) are capable of generating

219 seased cells with mutated genes into induced pluripotent stem cells (iPSCs) can allow studies of dise

220 aches to derive erythroid cells from induced pluripotent stem cells (iPSCs) created from patients are

221 NA sequencing in both mice and human induced pluripotent stem cells (iPSCs) derived from bipolar pati

222 chizophrenia (SCZ) when matured-from induced pluripotent stem cells (iPSCs) derived from healthy cont

223 al muscle models were developed from induced pluripotent stem cells (iPSCs) derived from healthy indi

224 ng a time course experiment of human induced pluripotent stem cells (iPSCs) differentiating into card

225 differential response, we generated induced pluripotent stem cells (iPSCs) from full responders and

226 IMPA1 deficiency in ID, we generated induced pluripotent stem cells (iPSCs) from patients and neuroty

227 Induced pluripotent stem cells (iPSCs) generated from individual

228 rogramming of human somatic cells to induced pluripotent stem cells (iPSCs) generates valuable resour

229 derived from embryonic stem cells or induced pluripotent stem cells (iPSCs) has been considered.

230 Induced pluripotent stem cells (iPSCs) have the potential to ove

231 impeded robust production from human induced pluripotent stem cells (iPSCs) in vitro.

232 Brain organoids derived from induced pluripotent stem cells (iPSCs) of the patients are a pow

233 Cardiomyocytes derived from human induced pluripotent stem cells (iPSCs) provide a unique opportun

234 The advent of human induced pluripotent stem cells (iPSCs) provided a means for avoi

235 Induced pluripotent stem cells (iPSCs) were generated from an in

236 velop cerebral organoid models using induced pluripotent stem cells (iPSCs) with APOE epsilon3/epsilo

237 issue-specific stem cells from human induced pluripotent stem cells (iPSCs) would have broad reaching

238 p formed by HGPS-SMCs generated from induced pluripotent stem cells (iPSCs), to study their vulnerabi

239 Using proband-derived induced pluripotent stem cells (iPSCs), we have successfully mod

240 se 2 (LRRK2) gene identified patient induced pluripotent stem cells (iPSCs), which were used to isola

241 es AD-related lysosomal defects in inducible pluripotent stem cells (iPSCs)-derived brain cells of Ap

242 her can convert human fibroblasts to induced pluripotent stem cells (iPSCs).

243 SNORD116 in neurons derived from PWS induced pluripotent stem cells (iPSCs).

244 and gene expression levels in human induced pluripotent stem cells (iPSCs).

245 iomyocyte differentiation from human induced pluripotent stem cells (iPSCs).

246 a PRC2.1 or 2.2 subcomplex in human induced pluripotent stem cells (iPSCs).

247 generated from PITRM1-knockout human induced pluripotent stem cells (iPSCs).

248 differentiated from patient-derived induced pluripotent stem cells is associated with cardioprotecti

249 of oncogenic polymorphisms arising in naive pluripotent stem cells is close to zero.

250 that provide a selective growth advantage in pluripotent stem cells is of concern for their clinical

251 ssible to produce, from embryonic or induced pluripotent stem cells, kidney organoids that represent

252 ioink to 3-dimensionally print human induced pluripotent stem cell-laden structures with 2 chambers a

253 erived from a commercially available induced pluripotent stem cell line (hiPSC) obtained from a human

254 mutations engineered in subclones of a human pluripotent stem cell line can be investigated in parall

255 xpression in neurons derived from an induced pluripotent stem cell line.

256 Under these conditions, we derive several pluripotent stem cell lines that express pluripotency-as

257 The introduction of induced pluripotent stem cell methodology enabled better modelin

258 d TNF-alpha using an in vitro murine induced pluripotent stem cell (miPSC) model system.

259 d a model of CSCs by culturing mouse induced pluripotent stem cells (miPSCs) for four weeks in the pr

260 on 3 of FMR1, we generated an isogenic human pluripotent stem cell model of FXS that shows complete l

261 harboring these mutations, a patient-induced pluripotent stem cell model was used.

262 We created a toolkit of human induced pluripotent stem cell models and functional assays using

263 utilize pluripotent stem cell models to demonstrate that a prima

264 at can be interrogated with species-matching pluripotent stem cell models.

265 additional FXS patient-derived human-induced pluripotent stem cell neural cells.

266 Dopaminergic neurons derived from induced pluripotent stem cells of PD patients carrying LRRK2 G20

267 After human induced pluripotent stem cells proliferated to a sufficient dens

268 In vitro differentiation of pluripotent stem cells provides a systematic platform to

269 Our knowledge of pluripotent stem cell (PSC) biology has advanced to the

270 Dynamic pluripotent stem cell (PSC) states are in vitro adaptati

271 The recent advent of human pluripotent stem cell (PSC)-derived 3D brain organoids h

272 Reprogrammed pluripotent stem cells (PSCs) are valuable for research

273 r epidermal vulnerabilities, patient-derived pluripotent stem cells (PSCs) conditional for the FA pat

274 Here, we engineer AEC2s from human pluripotent stem cells (PSCs) in vitro and use time-seri

275 Pluripotent stem cells (PSCs) transition between cell st

276 man somatic cells to primed or naive induced pluripotent stem cells recapitulates the stages of early

277 CRISPR-edited human induced pluripotent stem cells recapitulating the variant were d

278 human cardiac myocytes derived from induced pluripotent stem cells, replicating the effects of faili

279 A sequencing (RNA-seq) data from human naive pluripotent stem cells reported multiple point "mutation

280 model nuclear shape changes of human-induced pluripotent stem cells resulting from drug treatments.

281 Brain organoids grown from human pluripotent stem cells self-organize into cytoarchitectu

282 t that reprogramming to a stable naive human pluripotent stem cell state may effectively erase dysfun

283 riventricular endothelial cells, using human pluripotent stem cell technology, and extensively charac

284 cularly powerful in combination with induced pluripotent stem cell technology, which enables the deri

285 de in producing mature beta-cells from human pluripotent stem cells that respond appropriately to dyn

286 reated by the use of patient-derived induced pluripotent stem cells to generate both the motor neuron

287 also used cardiomyocytes derived from human pluripotent stem cells to model the contribution of TRPM

288 ortical spheroids derived from human induced pluripotent stem cells to replicate this neurodevelopmen

289 e cells differentiated in vitro from induced pluripotent stem cells to show that these cells exhibit

290 onic stem cells, and patient-derived induced pluripotent stem cells) to investigate the mechanism thr

291 Moreover, induced pluripotent stem cells used to model ND diseases are dis

292 human pancreatic alpha (SC-alpha) cells from pluripotent stem cells via a transient pre-alpha cell in

293 poietic potential of patient-derived induced pluripotent stem cells was skewed toward the myeloid lin

294 on human cardiomyocytes derived from induced pluripotent stem cells was then studied.

295 recursors, including patient-derived induced pluripotent stem cells, we further demonstrated that MCM

296 Here, using patient-derived induced pluripotent stem cells, we show that a mutation at the C

297 Here induced pluripotent stem cells were generated from control indiv

298 tive strategy is to print with human induced pluripotent stem cells, which can proliferate to high de

299 comprise dopamine neurons derived from human pluripotent stem cells, which have several advantages ov

300 ial for the long-term proliferation of human pluripotent stem cells, while their telomere length set